Výsledky vyhledávání - "Mutsumi Moriki"

Akademický článek

Late-onset development of psoriasis in Japan: a population-based cohort studyCapsule Summary

Autor: Haruka Goto, MD, Eiji Nakatani, PhD, Hiroaki Yagi, MD, PhD, Mutsumi Moriki, MD, Yuko Sano, MD, Yoshiki Miyachi, MD, PhD

Publikováno v: JAAD International, Vol 2, Iss , Pp 51-61 (2021)

Background: Evidence of factors associated with psoriasis from large population-based cohort studies is scarce. Objective: We aimed to explore the risk factors of late-onset psoriasis. Methods: This study included 487,835 Japanese participants aged 4

Externí odkaz: https://doaj.org/article/8b91af009bca4ce08c1eb4550dec34b6

Zobrazit plný text záznamu

Akademický článek

Scleredema accompanied by IgG‐λ monoclonal gammopathy

Autor: Haruka Goto, Mutsumi Moriki, Yuko Sano, Hiroaki Yagi, Yoshiki Tokura

Publikováno v: Journal of Cutaneous Immunology and Allergy, Vol 2, Iss 4, Pp 121-122 (2019)

Externí odkaz: https://doaj.org/article/1bb46d569696491c88a337f2824f98c9

Zobrazit plný text záznamu

Akademický článek

Subcutaneous granuloma annulare following influenza vaccination in a patient with diabetes mellitus

Autor: Takahiro Suzuki, Takatoshi Shimauchi, Mutsumi Moriki, Yoshiki Tokura

Publikováno v: Dermatologica Sinica, Vol 32, Iss 1, Pp 55-57 (2014)

An influenza vaccination often causes local reactions, such as induration and erythema at the injection site, and occasionally systemic reactions. The association between these reactions and influenza vaccinations has not been fully recognized. By co

Externí odkaz: https://doaj.org/article/40ed97d9eec54e2191140f4957728249

Zobrazit plný text záznamu

A case of Sézary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthritis

Autor: Kandai Saito, Takatoshi Shimauchi, Reiko Kageyama, Seri Furukawa, Norihito Suzuki, Atsuyoshi Ginoza, Mutsumi Moriki, Taisuke Ito, Tetsuya Honda

Publikováno v: Clinical and Experimental Dermatology. 48:391-393

The risk of developing malignancies including cutaneous T-cell lymphoma with use of Janus kinase inhibitors is of concern. Here, we describe a case of Sézary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthrit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c081096b4fb873994cc9ebd1607b6972
https://doi.org/10.1093/ced/llac124

Zobrazit plný text záznamu

Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration

Autor: Tomonori Suzuki, Daichi Kamiya, Hiyori Fujino, Kazuhiro Asada, Tomonobu Uchino, Hajime Mizuno, Yuko Sano, Hiroaki Yagi, Midori Kimura, Kenichiro Todoroki, Toshihiro Shirai, Mutsumi Moriki, Yasunori Miyazaki, Yoshiyuki Kagawa

Publikováno v: Cancer Chemotherapy and Pharmacology. 86:233-243

Erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, causes skin disorders such as dry skin, which impairs the skin barrier function. Stratum corneum (SC) lipids play an important role in skin barrier function; therefore,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a55f6ad8ab475b97f15d22382e25e22
https://doi.org/10.1007/s00280-020-04095-z

Zobrazit plný text záznamu

Late-onset development of psoriasis in Japan: a population-based cohort study

Autor: Mutsumi Moriki, Hiroaki Yagi, Yoshiki Miyachi, Yuko Sano, Eiji Nakatani, Haruka Goto

Publikováno v: JAAD International

Background Evidence of factors associated with psoriasis from large population-based cohort studies is scarce. Objective We aimed to explore the risk factors of late-onset psoriasis. Methods This study included 487,835 Japanese participants aged 40-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aed6408af06955fd47d13b213c9e608
https://pubmed.ncbi.nlm.nih.gov/34409354

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání